Lars Sternås
- Oncology top 5%
- Cancer Treatment and Pharmacology 15
- Viral-associated cancers and disorders 7
- CAR-T cell therapy research 4
- Lung Cancer Research Studies 4
- Immunology top 5%
- Hematology top 5%
- Multiple Myeloma Research and Treatments 29
-
- Lymphoma Diagnosis and Treatment 5
- Hepatology top 10%
-
- Protein Degradation and Inhibitors 15
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- F GrignaniRiccardo Dalla‐FaveraCraig W. ReynoldsLarry W. KwakRobin PenningtonMaurizio BendandiFloyd A. BenkoElaine S. Jaffe
- Cited by
- OncologyImmunologyHematology
- Partner nations
- United StatesSpainGreece
In The Last Decade
Lars Sternås
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 76
- Oncology 866
- Immunology 516
- Hematology 265
- Pathology and Forensic Medicine 278
- Hepatology 103
Countries citing papers authored by Lars Sternås
This map shows the geographic impact of Lars Sternås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Sternås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Sternås more than expected).
Fields of papers citing papers by Lars Sternås
This network shows the impact of papers produced by Lars Sternås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Sternås. The network helps show where Lars Sternås may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Sternås, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 24 | |
| 2 | 2017 | 1 | |
| 3 | 2017 | 10 | |
| 4 | 2016 | 21 | |
| 5 | OUTCOMES FOR OLDER PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE STRATUS (MM-010) TRIAL, A SINGLE-ARM, PHASE 3B STUDY | 2015 | 1 |
| 6 | THE STRATUS (MM-010) TRIAL: A SINGLE-ARM, PHASE 3B STUDY EVALUATING SAFETY AND EFFICACY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA | 2015 | 1 |
| 7 | ANALYSIS OF PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE PHASE 3B STRATUS TRIAL (MM-010) | 2015 | 3 |
| 8 | 2015 | 35 | |
| 9 | 2015 | 1 | |
| 10 | 2014 | 14 | |
| 11 | Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone | 2014 | 1 |
| 12 | 2014 | 9 | |
| 13 | 2013 | 39 | |
| 14 | 2011 | 7 | |
| 15 | 2011 | 69 | |
| 16 | 2010 | 68 | |
| 17 | 2009 | 183 | |
| 18 | 2008 | 19 | |
| 19 | 1999 | 458 | |
| 20 | 1990 | 4 |
About Lars Sternås
Lars Sternås is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Reproductive Medicine, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Cancer Treatment and Pharmacology (15 papers), Protein Degradation and Inhibitors (15 papers), Viral-associated cancers and disorders (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (866 citations), Immunology (516 citations), Hematology (265 citations), Pathology and Forensic Medicine (278 citations) and Hepatology (103 citations). Lars Sternås has collaborated with scholars based in United States, Spain and Greece. Frequent co-authors include F Grignani, Riccardo Dalla‐Favera, Craig W. Reynolds, Larry W. Kwak, Robin Pennington, Maurizio Bendandi, Floyd A. Benko, Elaine S. Jaffe, P L Duffey and Carol B. Kobrin. Their work appears in journals such as Journal of Clinical Oncology, Blood, Haematologica, Journal of Immunological Methods and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.